Cargando…

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare entity whose neoplastic cells retain a B-cell phenotype with expression of CD20. Radiotherapy is recommended for favorable stage IA disease while for other stages guidelines suggest therapeutic strategies similar to those used for cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotti, Manuel, Sciarra, Roberta, Pulsoni, Alessandro, Merli, Francesco, Luminari, Stefano, Zerbi, Caterina, Trentin, Livio, Re, Alessandro, Rusconi, Chiara, Viviani, Simonetta, Rossi, Andrea, Cocito, Federica, Botto, Barbara, Meli, Erika, Pinto, Antonello, Dogliotti, Irene, Gini, Guido, Puccini, Benedetta, Ricci, Francesca, Nassi, Luca, Fabbri, Alberto, Liberati, Anna Marina, Merli, Michele, Filippi, Andrea Riccardo, Bonfichi, Maurizio, Zoboli, Valentina, Tartaglia, Germana, Annechini, Giorgia, D’Elia, Gianna Maria, Del Giudice, Ilaria, Alvarez, Isabel, Visentin, Andrea, Pravato, Stefano, Dalceggio, Daniela, Pagani, Chiara, Ferrari, Silvia, Cristinelli, Caterina, Lazic, Tanja, Ferretti, Virginia Valeria, Ricardi, Umberto, Arcaini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079338/
https://www.ncbi.nlm.nih.gov/pubmed/37034003
http://dx.doi.org/10.1097/HS9.0000000000000837